January 20, 2017 /

Vamorolone (VBP15) Clinical Trials in Duchenne (January 2017)

Vamorolone (VBP15) Clinical Trials in Duchenne (January 2017)

On January 18, 2017, PPMD was joined by ReveraGen BioPharma for a webinar discussion on vamorolone (VBP15) clinical trials in Duchenne. Dr. Eric Hoffman presented a brief history of the vamorolone program, explained current and anticipated clinical trials, and answered community questions.


Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo